ARTICLE | Company News
Morphochem, Aventis deal
March 26, 2001 8:00 AM UTC
Morphochem and AVE’s Aventis Pharma AG subsidiary (Frankfurt, Germany) will develop compounds against an undisclosed AVE diabetes target using Morphochem’s high throughput chemical genomics technology...